Don't restrict funding from drug companies for doctors' education

BMJ ◽  
2013 ◽  
Vol 347 (nov08 1) ◽  
pp. f6452-f6452 ◽  
Author(s):  
N. Skolnik
Keyword(s):  
Drug Companies

AIDS Drugs & the Pharmaceutical Industry: A Need For Reform

1991 ◽  
Vol 17 (4) ◽  
pp. 363-410
Author(s):  
Mary T. Griffin
Keyword(s):  
Pharmaceutical Industry ◽  
Research And Development ◽  
Drug Approval ◽  
Hiv And Aids ◽  
Price Regulation ◽  
Drug Industry ◽  
Drug Companies ◽  
Aids Drugs

AbstractThe pharmaceutical industry has long enjoyed substantial profits despite increased requirements for drug approval and various attempts to regulate the industry. Drug companies have avoided effective regulation by blaming high prices on the costs of research and development. The search for drugs effective in combatting HIV and AIDS related illnesses has provided a stark background on which to view the actions and justifications of drug companies. Despite increased cooperation between government and the drug industry and expedited approval of several useful drugs, these drugs are still prohibitively expensive. This Article explores the history and economics of the drug industry and proposes a system of national price regulation for all drugs.

DRUG COMPANIES AND JOURNAL SUPPLEMENTS

The Lancet ◽  
1986 ◽  
Vol 327 (8490) ◽  
pp. 1157 ◽  
Author(s):  
RobertL. Cohen
Keyword(s):  
Drug Companies

Drug Companies Push Into Central Europe

2006 ◽  
Vol 84 (14) ◽  
pp. 16 ◽  
Author(s):  
MICHAEL MCCOY ◽  
JEAN-FRANÇOIS TREMBLAY
Keyword(s):  
Central Europe ◽  
Drug Companies

Feature

2010 ◽  
Vol 14 (05n06) ◽  
pp. 22-38
Keyword(s):  
Cancer Patients ◽  
Biodiversity Conservation ◽  
Mobile Health ◽  
Health Records ◽  
Drug Companies ◽  
A Priority ◽  
Vein Harvesting

Biodiversity Conservation is Everyone's Business. Search for ASEAN Champions of Biodiversity is On. Drug Companies Reduce Prices of Medicines. SWS: Make Health A Priority, Filipinos Ask Next Leaders. New Vein Harvesting Technology. Mobile Health Records in Malaysia. Faster, Accurately Targeted Radiation Cancer Patients. SingHealth Selects IBM and SAP To Transform HR Processes.

Pharmaceutical Promotion in the Third World

1992 ◽  
Vol 22 (2) ◽  
pp. 417-453 ◽  
Author(s):  
Joel Lexchin
Keyword(s):  
Pharmaceutical Industry ◽  
Health Care Professionals ◽  
Third World ◽  
Marketing Practice ◽  
Professional Groups ◽  
The Third ◽  
Pharmaceutical Manufacturers ◽  
Drug Companies ◽  
Pharmaceutical Promotion ◽  
The Third World

The pharmaceutical industry is motivated by profit and it is the quest for ever larger sales and profits that determines how the industry promotes its products. The author analyzes the methods that drug companies use in marketing their drugs to doctors and consumers, and the consequences in terms of costs and health. Some of the drugs advertised are valuable; others are irrational mixtures, useless or dangerous and should not be on the market. Even for products of proven worth, the companies have a double standard when it comes to promoting them in the Third World. The International Federation of Pharmaceutical Manufacturers Associations does have a Code of Marketing Practice, but major weaknesses in the code render it almost impotent in regulating promotion. When consumers and health care professionals question the tactics of the industry, the response is usually to attack the credibility of the critics rather than to deal with the issues that they raise. Physicians and consumers are strongly influenced by pharmaceutical promotion, with all too predictable results: Doctors prescribe irrationally and consumers develop grossly distorted ideas about the value of modern medications. Reforms to promotional practices are possible, but may be beyond the resources of Third World countries. Achieving these reforms will require the efforts of Third World countries, progressive elements in the pharmaceutical industry, consumer and professional groups and some form of organized international support.

Drug companies withdraw law suit against South Africa

BMJ ◽  
2001 ◽  
Vol 322 (7293) ◽  
pp. 1011-1011 ◽  
Author(s):  
P. Sidley
Keyword(s):  
South Africa ◽  
Drug Companies

scholarly journals How the Lifestyle Leaders View and Manage Medications

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 611-612
Author(s):  
Taylor Patskanick ◽  
Julie Miller
Keyword(s):  
Side Effects ◽  
Medication Management ◽  
Healthcare Providers ◽  
Prescription Medication ◽  
The Internet ◽  
Prescription Medications ◽  
Over The Counter ◽  
Attitudes And Behaviors ◽  
The Past ◽  
Drug Companies

Abstract Medication management is an ongoing consideration for adults ages 85 and older, their caregivers, and healthcare providers. When asked about their attitudes and behaviors regarding medication management, over 73% of the Lifestyle Leaders reported taking 3+ prescription medications daily and managing their own medication regimes. 61.9% of participants had taken over-the-counter, non-prescription medication for pain over the past five years. When asked why some participants didn’t currently take prescription medications to manage pain, the most frequently-reported responses were: “I don’t feel that my pain warrants a prescription medication,” (19%, n=8), “I don’t want to deal with the side effects,” and “I don’t trust drug companies,” (9.5%, n=4, respectively). The Lifestyle Leaders reported they would be most likely to go to the internet (over their local pharmacist) to ask for advice about their medication(s). Meanwhile, 39% of Lifestyle Leaders would trust a robot to manage their medication(s) for them.

Sign in / Sign up

Export Citation Format

Share Document